References
- Sears MR. Worldwide trends in asthma mortality. Bull bit Union Tuberc Lung Dis 1991; 66: 79
- Bauman A, Cooper C, Webb C, Tse M, Miles D, Bhasale A, Pollock M. Asthma management and morbidity in Australian general practice: The relationship between patient and doctor estimates. Respir Med 1995; 89: 665
- LAIA Trends in hospital admissions for asthma. Factsheet London 1995; 95(1)
- Sears M R, Rea HH. Patients at risk for dying of asthma: New Zealand experience. J Allergy Clin Immunol 1987; 80: 477
- Garrett A M, Kolbe J, Richards G, Whitlock T, Rea H. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: What lessons have been learned?. Thorax 1995; 50: 303
- Kendrick A H, Higgs C MB, Whitfield M J, Laszlo G. Accuracy of perception of severity of asthma: Patients treated in general practice. Br Med J 1993; 307: 422
- Guidelines on the management of asthma. Thorax. 1993; 48: 51
- Sibbald B. Patient self care in acute asthma. Tliorax 1989; 44: 97
- Fleiss JL. Statistical Metlwds for Rates and Proportions. Wiley, New York 1981
- Van Ganse E H, van der, Linden P D, Leufkens H GM, Herings R, Vincken W, Ernst P. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. Eur Respir J 1995; 8: 1856
- Cochrane GM. Therapeutic compliance in asthma: Its magnitude and implications. Eur Respir J 1992; 5: 122
- Dekker F W, Dieleman F E, Kaptein A A, Mulder JD. Compliance with pulmonary medication in general practice. Eur Respir J 1993; 6: 886
- Ernst P, Spitzer W, Suissa S, Cockroft D, Habbick B, Horwitz R I, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992; 268: 3462
- Yeung M, O'Connor S A, Parry D T, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir Med 1994; 88: 31
- Bone RC. The bottom line in asthma management is patient education. Am J Med 1993; 94: 561
- Partridge MR. Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education?. Eur Respir J 1995; 8: 298
- Osman L M, Russell I T, Friend J AR, Legge J S, Douglas JG. Predicting patient attitudes to asthma medication. Thorax 1993; 48: 827
- Van Ganse E. Use of databases in pharmacovigilance: two examples. Therapie 1995; 50: 409
- Evans D. To help patients control asthma, the clinician must be a good listener and teacher. Tliorax 1993; 48: 685
- Van Essen-, Zandvliet E E, Hughes M D, Waalkens H J, Duiverman E J, Pocock S J, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992; 346: 547
- Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koski-nen S, Lehtonen K, et al. Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388
- Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868
- Gilley J. Towards rational prescribing. Br Med J 1994; 308: 731